Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Randomised controlled trials are the gold standard for testing the efficacy and safety of health interventions, especially medications, and researchers in the U.K. are required to gain approval from ethics committees, the regulatory body (Medicines and Healthcare products Regulatory Agency) and local NHS research governance departments for such trials. Although research governance is important to reassure trial participants that their rights and interests are protected, current practice is impeding research and presents a genuine threat to the U.K. and to the NHS's ability to deliver high-quality evidence on which doctors can base clinical decisions and improve the delivery of care. This article discusses recent experience of running large-scale clinical trials and suggests measures that could improve the current situation.

Original publication

DOI

10.7861/clinmedicine.10-2-127

Type

Journal article

Journal

Clin Med (Lond)

Publication Date

04/2010

Volume

10

Pages

127 - 129

Keywords

Clinical Governance, Clinical Trials as Topic, Humans, Randomized Controlled Trials as Topic, Research Support as Topic, State Medicine, United Kingdom